CTNM
#3230
Contineum Therapeutics, Inc. - Common stock
14.5 7 USD
0.00%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.34%
Variación mensual
+15.00%
Variación en los últimos 6 meses
-4.58%
Cambio anual
-4.58%
Cierres anteriores
14.6 2
Open
14.5 7
Mínimo
14.5 7
High
14.5 7
Volumen
63
Financials
- Market Capitalization 336.55 M
- Employee 51
- Founded 2009
- CEO N/A
- Website www.contineum-tx.com
- Headquarter Delaware, United States
- FIGI BBG01M27SVP6
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3225 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 4.77 USD | +3.25% | 0.00% | +26.86% | +253.33% | 339.56 M USD | ||
| 3229 |  IMRX Immuneering Corporation - Class A Common Stock | 5.21 USD | +0.97% | +0.97% | +24.34% | +28.33% | 337.07 M USD | ||
| 3232 |  PALI Palisade Bio, Inc. - Common Stock | 1.93 USD | +2.12% | -5.85% | +14.88% | +13.53% | 335.01 M USD | ||
| 3295 |  FHTX Foghorn Therapeutics Inc. - Common Stock | 5.38 USD | -1.10% | -8.97% | +30.58% | +31.86% | 315.88 M USD |